U.S. pharma huge copyright scrapped two experimental weight loss tablets final yr—a after-each day capsule, lotiglipron, because of elevated liver enzymes along with a 2 times-day by day pill, danuglipron, as a result of sturdy Negative effects—but CEO Albert Bourla has claimed the c